Faculty Co-Chairs

Scott H. Kollins, PhD, MS
Professor & Vice Chair for Research Strategy & Development
Director, Duke ADHD Program
Department of Psychiatry & Behavioral Sciences
Department of Psychology & Neuroscience
Duke University School of Medicine
Durham, North Carolina

Richard H. Weisler, MD
Adjunct Professor of Psychiatry
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
Adjunct Assistant Professor of Psychiatry
Duke University Medical Center
Durham, North Carolina
Private Practice
Raleigh, North Carolina

Accredited By

Integrity Continuing Education, Inc.

Activity Details


0.75 AMA PRA Category 1 Credit(s)

Released: April 21, 2017

Expires: April 21, 2018

0.75 hour(s) to complete

No registration required

Target Audience

This educational initiative has been designed for psychiatrists and internal medicine physicians involved in the care of adult patients with ADHD.

Learning Objectives

  • Describe DSM-5 diagnostic criteria for attention-deficit/hyperactivity disorder (ADHD) in adults and the differences in symptoms compared with children
  • Review stimulant and non-stimulant therapies and the treatment of executive functioning in adults with ADHD
  • Identify the most frequent psychiatric comorbidities in adults with ADHD and discuss an approach to management

Conflict of Interest Policy/Disclosure Statement

Integrity Continuing Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The following faculty/planners reported the financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of these CME activities:

Scott H. Kollins, PhD, MS
Consultant: Akili Interactive, Alcobra Pharma, Atentiv, Inc., Ironshore Pharmaceuticals & Development, Inc., Neurovance, Rhodes Pharmaceuticals, Shire, SK Life Science, Inc.
Research Grants: Akili Interactive, Alcobra Pharma, Arbor Pharmaceuticals, Atentiv, Inc., Environmental Protection Agency, Food & Drug Administration, Ironshore Pharmaceuticals & Development, Inc., John T. Templeton Foundation, Medgenics, Inc., National Institutes of Health (NIDA, NIMH, NICHD, NIEHS), Neos Therapeutics, Neurovance, Purdue, Rhodes Pharmaceuticals, Shire, Sunovion Pharmaceuticals, Inc.

Richard H. Weisler, MD
Consultant: Alcobra Pharma, AltheaDx, Inc., Ironshore Pharmaceuticals & Development, Inc., Lundbeck, Major League Baseball, National Football League, Neos Therapeutics, Nestle Health Science-PamLab, Inc., Otsuka America Pharmaceuticals, Rhodes Pharmaceuticals, Shire, Sunovion Pharmaceuticals, Inc., Supernus Pharmaceuticals, Validus Pharmaceuticals
Research Grants: Alcobra Pharma, Allergan, Daiichi Sankyo Pharma, Genomind, Janssen Pharmaceutical, Merck, Neurim Pharmaceuticals, Otsuka America Pharmaceuticals, Roche-Genentech, Shire, Theravance Biopharma
Speaker’s Bureau: Lundbeck, Neos Therapeutics, Nestle Health Science-PamLab, Inc., Otsuka America Pharmaceuticals, Rhodes Pharmaceuticals, Shire, Sunovion Pharmaceuticals, Inc., Validus Pharmaceuticals

Sean Gregory, PhD, hereby states that he or his spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Accreditation Statement

Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation of Credit

Integrity Continuing Education, Inc. designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Statement of Commercial Support

Supported by an educational grant from Shire.


The information provided at this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity Continuing Education and Shire do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Contact Information for Questions about the Activity

For information about the accreditation of this activity, please contact Integrity Continuing Education at (855) 835-4004 or

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.